Turnover of [14C]thiamin and activities of thiamin pyrophosphate-dependent enzymes in tissues of mice with Ehrlich ascites carcinoma. 1984

R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov

Turnover of [14C]thiamin was studied in mice with Ehrlich ascites carcinoma fed a thiamin-deficient diet and injected with 5 or 2 micrograms/mouse of the labeled vitamin. The process of conversion of [14C]thiamin to thiamin pyrophosphate (TPP) was monitored by measuring the activities of transketolase, pyruvate dehydrogenase, and oxoglutarate dehydrogenase. The amount of coenzyme-unsaturated apotransketolase was assessed by measuring the TPP effect--determining transketolase activity with and without the addition of TPP in vitro. Tumor growth was accompanied by thiamin deficiency, manifested in an increase in [14C]thiamin incorporation into the host tissues and the absence of saturation of the tissues with the labeled vitamin over 13 days. Increased values for the turnover coefficients, reduction of thiamin-dependent enzyme activities, elevation of the TPP effect, and a decrease in urinary excretion of the radioactive products also provided evidence for a disturbance in thiamin metabolism. The severity of the disturbance in thiamin metabolism during malignant tumor growth was directly related to the dose of the exogenous vitamin.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013831 Thiamine 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride. Aneurin,Vitamin B 1,Thiamin,Thiamine Mononitrate,Vitamin B1,Mononitrate, Thiamine
D013832 Thiamine Deficiency A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. (From Cecil Textbook of Medicine, 19th ed, p1171) Deficiency, Thiamine,Deficiencies, Thiamine,Thiamine Deficiencies
D013835 Thiamine Pyrophosphate The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the PYRUVATE DEHYDROGENASE COMPLEX and the KETOGLUTARATE DEHYDROGENASE COMPLEX. Cocarboxylase,Thiamine Diphosphate,Berolase,Pyrophosphate, Thiamine
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D014815 Vitamins Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. Vitamin

Related Publications

R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
December 1984, Cancer letters,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
May 1976, The Journal of biological chemistry,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
January 1981, Voprosy pitaniia,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
January 2011, Bulletin of experimental biology and medicine,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
January 1971, Experientia,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
November 2004, Bulletin of experimental biology and medicine,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
October 1969, Strahlentherapie,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
January 1992, Journal of nutritional science and vitaminology,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
June 1972, Experientia,
R V Trebukhina, and Y M Ostrovsky, and V S Shapot, and G N Mikhaltsevich, and V N Tumanov
January 1982, Cancer research,
Copied contents to your clipboard!